Home▸Articles▸Geriatric Polypharmacy Deprescribing

Understanding Anticholinergic Burden: A Key Metric in Geriatric Polypharmacy

Anticholinergic burden is a critical concept for healthcare professionals managing the complex medication regimens of older adults.

mysimulator teamUpdated June 2026≈ 3 min read▶ Open the simulation

What Anticholinergic Burden Is

Anticholinergic burden refers to the cumulative effect of medications that block acetylcholine, a neurotransmitter involved in cognitive function, memory, and learning. This term is particularly relevant in geriatric care due to the high prevalence of polypharmacy among older adults.

The anticholinergic burden score (ABS) quantifies the total impact of these drugs on an individual patient by summing up their contributions from each medication.

Why It Matters

High anticholinergic burden has been linked to cognitive decline, confusion, and increased risk of falls in elderly patients. By assessing this burden, healthcare providers can identify potential risks associated with a patient's current medication regimen.

Optimizing drug therapy by reducing or substituting high-anticholinergic drugs can help minimize adverse effects while maintaining necessary therapeutic benefits.

live demo · related simulation● LIVE

How It Is Calculated

The anticholinergic burden score is calculated based on the number of medications a patient is taking and their individual anticholinergic activity. Each drug has an assigned score, and these scores are summed to give the total anticholinergic burden.

This process involves evaluating each medication's potential for anticholinergic effects and assigning it a score from 0 (no effect) to 4 (highly anticholinergic).

Real-World Applications

Healthcare professionals use the anticholinergic burden score as part of their decision-making process when considering deprescribing or substituting medications. This tool helps in identifying which drugs might be contributing to cognitive decline and guides the selection of alternative treatments.

Regular assessment of anticholinergic burden can lead to improved patient outcomes by reducing the risk of adverse effects while maintaining necessary therapeutic benefits.

Frequently asked questions

What are some common medications that contribute to high anticholinergic burden?

Common culprits include tricyclic antidepressants, antihistamines, and certain pain relievers. These drugs often have significant anticholinergic effects.

How can a healthcare provider reduce the anticholinergic burden of a patient's medication regimen?

By carefully reviewing the patient’s current medications, identifying those with high anticholinergic activity, and considering alternative treatments or lower doses that have fewer side effects.

Is there a threshold for an anticholinergic burden score above which cognitive decline is guaranteed?

No, while higher scores are associated with increased risk of adverse effects, the relationship between anticholinergic burden and cognitive function is complex. Other factors also play a role.

Can non-pharmacological interventions help reduce anticholinergic burden?

While not directly reducing medication use, lifestyle changes such as physical exercise, mental stimulation, and social engagement can complement pharmacological management to improve cognitive function.

Try it live

Everything above runs in your browser — open Anticholinergic Burden Cognitive Risk Calculator and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.

▶ Open Anticholinergic Burden Cognitive Risk Calculator simulation

What did you find?

Add reproduction steps (optional)